cTnI Monitoring
CARDIAC TROPONIN I MONITORING IN BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINEOR TRASTUZUMAB THERAPY: a pilot study
The main aim of the study is to understand how and when the levels of cardiac troponin I change in breast cancer patients and to monitor how the levels change throughout breast cancer treatment.
Chief Investigator: Dr Peter Henriksen
Number and location of participating sites (by region/ country): UK 3 sites
Funder: Edinburgh and Lothians Health Foundation
Start and End Date of grant award
Status: Complete
UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document.
Sponsor: Mrs Susan Shepherd ACCORD
Chief Investigator: Dr Peter Henriksen, Edinburgh Heart Centre, Western General Hospital, Edinburgh EH4 2XU.
Trial manager: Morag MacLean, ECTU morag.maclean@ed.ac.uk
Research nurse: Heather McVicars, Edinburgh Cancer Centre Heather.McVicars@nhslothian.scot.nhs.uk
Or Karen Bell, Beatson West of Scotland Cancer Centre Karen.Bell@ggc.scot.nhs.uk
ECTU Involvement: Trial management / Database